首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmaceutical sciences

缩写:J PHARM SCI-US

ISSN:0022-3549

e-ISSN:1520-6017

IF/分区:3.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引7287
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Eqram Rahman,Alain Michon,Parinitha Rao et al. Eqram Rahman et al.
Botulinum neurotoxin type A (BoNT/A) formulations differ mainly in excipients, which determine stability, aggregation, and diffusion. Using multi-scale in silico modelling (AesthetiSIMTM), we evaluated excipient substitution across six mark...
Kassem Al Attabi,Farag M A Altalbawy,Deepak J et al. Kassem Al Attabi et al.
Benzimidazole, a compound valued for its distinct physicochemical characteristics and diverse applications, is the focus of this investigation into its dissolution behavior across various monosolvents. This research employs sophisticated ma...
Tianyu He,Rong Tian,Zhichao Song et al. Tianyu He et al.
Natural terpenes found in essential oils (EOs) have shown promise as penetration enhancers (PEs) in pharmaceutical and cosmetic formulations. This study compared the skin penetration enhancement properties of sesquiterpenes and monoterpenes...
İbrahim Hakkı Demircioğlu,Oğuzhan Dalkılıç,Saffet Çelik et al. İbrahim Hakkı Demircioğlu et al.
Extractables and Leachables studies require highly reliable and sensitive analytical methods to ensure pharmaceutical product safety. Plastic additives are widely used during production to improve the physicochemical properties of polymeric...
Russell O Potts Russell O Potts
A review of the Potts-Guy equation and its impact on drug delivery. Keywords: PhD; Russell O. Potts. ...
Narasimha Swamy Kollu,Ravikiran Allada Narasimha Swamy Kollu
The presence of particles in injectable formulations presents significant risks, such as embolism, phlebitis, and thrombophlebitis. Moreover, visible particles violate pharmacopeial standards and may lead to regulatory actions. Therefore, i...